Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$1.94 - $4.61 $27,014 - $64,194
-13,925 Reduced 8.79%
144,452 $556,000
Q1 2024

May 15, 2024

SELL
$1.99 - $5.64 $28,447 - $80,623
-14,295 Reduced 8.28%
158,377 $351,000
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $262,816 - $877,482
85,608 Added 98.33%
172,672 $934,000
Q3 2023

Nov 14, 2023

BUY
$10.52 - $20.68 $915,913 - $1.8 Million
87,064 New
87,064 $947,000
Q3 2022

Nov 14, 2022

SELL
$14.67 - $21.7 $590,863 - $874,010
-40,277 Reduced 62.17%
24,511 $390,000
Q2 2022

Aug 15, 2022

BUY
$13.46 - $48.16 $277,276 - $992,095
20,600 Added 46.62%
64,788 $963,000
Q1 2022

May 16, 2022

SELL
$34.22 - $47.24 $510,288 - $704,442
-14,912 Reduced 25.23%
44,188 $2.01 Million
Q4 2021

Feb 14, 2022

BUY
$43.29 - $58.77 $59,999 - $81,455
1,386 Added 2.4%
59,100 $2.72 Million
Q3 2021

Nov 15, 2021

BUY
$36.86 - $54.98 $2.13 Million - $3.17 Million
57,714 New
57,714 $2.85 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.